STUDY QUESTION: Does starting IUI with ovarian stimulation (IUI-OS) within 1.5 years after completion of the fertility workup increase ongoing pregnancy rates compared to expectant management in couples with unexplained subfertility?
Introduction
Couples who have been trying to conceive for at least 12 months and whose fertility workup fails to reveal any abnormalities are considered to have unexplained subfertility (Aboulghar et al., 2009; Brandes et al., 2010) . IUI is often used as first-line treatment in these couples, especially in combination with ovarian stimulation (OS), since it is less invasive and less costly than IVF (Tjon- Kon-Fat et al., 2015) , despite conflicting evidence from randomized controlled trials regarding the effectiveness of IUI-OS. The two trials that compared IUI-OS to expectant management used different thresholds for the prognosis of natural conception as inclusion criteria. In women with an intermediate prognosis to conceive naturally, i.e. an estimated probability between 30 and 40% to conceive within 12 months leading to live birth, IUI-OS was not more effective than expectant management (Steures et al., 2006) . In women with a poor prognosis, i.e. <30% over 12 months, IUI-OS resulted in more live births than expectant management (Farquhar et al., 2018) .
The results of these two trials suggest that IUI-OS might be effective in couples with a poor prognosis, whereas it might be ineffective in couples with better prognoses. For example, couples who have been trying to conceive for a longer period of time and where the female partner is older and/or nulliparous might derive greater benefit from treatment (McLernon et al., 2014) . However, these two trial results cannot be taken as definite evidence that we should treat all couples with a poor prognosis of natural conception. Other -unmeasured-differences between the two trials could also explain the different results. The hypothesis that the prognostic profile of a couple determines the benefit of IUI-OS thus needs to be addressed directly in a single population that is heterogeneous in terms of their prognosis of natural conception. Knowledge on who is more likely to conceive with IUI-OS is critical in informing clinical decision making and avoids unnecessary treatment in some while ensuring early and appropriate access to active treatment in others.
The aim of this study was to determine the chances of conception after expectant management or starting IUI-OS in a cohort of unexplained subfertile couples that included couples who followed both strategies.
Materials and Methods

Patient selection
Couples were selected from a prospective cohort recruited across 38 hospitals in The Netherlands between January 2002 and February 2004, the detailed protocol for which has been described elsewhere . The purpose of recruiting this cohort was to validate the Hunault model to predict the chances of natural conception leading to live birth (Hunault et al., 2004) . In 7 of these 38 centres, data on IUI cycles was also recorded and used to validate a prediction model for chances of ongoing pregnancy per IUI cycle (Steures et al., 2004; Custers et al., 2007) . IVF pregnancy outcome data were not routinely collected but starting dates of IVF treatment were known. Couples from the seven centres that recorded IUI data were included in the current study.
We defined subfertility as couples trying to conceive for at least 12 months Gnoth et al., 2005) . Selected subfertile couples had regular menstrual cycles (cycle length between 23 and 35 days), at least one patent fallopian tube if hysterosalpingography, laparoscopy or transvaginal hydrolaparoscopy was performed and a total motile sperm count >1 × 10 6 .
Women were evaluated for tubal patency according to the Dutch national guidelines and protocols from 2002 to 2004 recommending the chlamydia antibody test (CAT) as the first-line test (NVOG, 2004) . In women who were CAT negative, invasive diagnostic testing was usually refrained from, thus limiting tubal patency testing to the CAT (Broeze et al., 2011) . Women who tested positive on the CAT, or if their history indicated a high risk of tubal pathology, were subsequently tested with hysterosalpingography, transvaginal hydrolaparoscopy or laparoscopy.
Decisions regarding treatment-IUI, IVF or expectant management -were made according to local protocols and subject to the judgement of the clinician and the wishes of the couple. Expectant management was defined as no intervention or monitoring aside from the advice to have intercourse. In total, 83% of couples who received IUI used stimulation in at least one cycle and treatment was considered IUI-OS. The IUI protocols have been described in more detail elsewhere (Custers et al., 2007) .
Follow up and outcome definitions
For the follow up of selected couples, we distinguished between time spent pursuing expectant management and time spent receiving IUI-OS cycles. The start of the IUI period was defined as the first day of menstruation before the first IUI cycle. The end of the IUI period was defined as the first day of menstruation before the last IUI cycle. With this definition, and because natural conceptions after unsuccessful IUI cycles were not recorded, all pregnancies in the IUI period resulted from IUI. The start of expectant management coincided with the completion of the fertility workup and ended at the last date of contact, first day of last menstruation before starting IUI or IVF or, in case they conceived naturally, the first day of the last menstruation before conceiving. We visualized the transition from expectant management to IUI-OS in the cohort by counting the number of couples in both groups over follow up.
The endpoint was ongoing pregnancy, defined as the presence of foetal cardiac activity at transvaginal sonography at a gestational age of at least 12 weeks . Couples who miscarried before 12 weeks were not censored since they could still achieve ongoing pregnancy in subsequent cycles after their miscarriage. If no ongoing pregnancy occurred, we censored follow up at the end of expectant management or, if treated, at the end of the IUI period.
Cumulative pregnancy rates over multiple IUI cycles
We opted for the Sequential Cox approach to be able to compare treated and untreated couples over multiple cycles after starting treatment, not only directly after completion of the fertility workup but also if they started later (Gran et al., 2010) .
In this approach, we derived multiple datasets from the cohort in which couples started IUI-OS at approximately the same point in time and compared them to couples undergoing expectant management at that time, mimicking hypothetical randomized controlled trials (Gran et al., 2010) . At completion of the fertility workup and each consecutive month thereafter, i.e. the landmark time points, we constructed such a new mimicked trial from our data in which we included all couples who remained in the cohort, i.e. couples who had not conceived and who were not lost to follow up before that point. In these 'trial' sets spanning 6 months, we considered couples as treated if they started IUI-OS early, i.e. within one month after the landmark time point. Couples who started IUI-OS within the 6 months window of a trial, but later than one month after the landmark time point, were 'artificially censored' at the time of starting IUI-OS to retain a treatment group that all started at approximately the same time. This way, couples were not included in a single group throughout the study. Instead, couples who started IUI-OS were analysed as controls (under expectant management) in the trials preceding the month in which they started IUI-OS, at which point they were analysed over cumulative treatment cycles as part of the treated (IUI-OS) group in the mimicked trial that started that month.
The maximum follow up period of 18 months after the fertility workup was chosen because of the small numbers of couples starting treatment thereafter. Thus, we derived trial datasets from landmark time point 0, i.e. the fertility workup until the final landmark time point at 12 months after the workup, sliding forward in intervals of 1 month, resulting in a total of 13 mimicked trials.
Adjusting for patient characteristics that differed between treated and untreated couples
To balance treated, untreated, artificially censored and uncensored couples in important predictors of conception, we applied iterative inverse probability weighting (Austin, 2011; van der Wal, 2011; Austin and Stuart, 2015) . Details on how we derived the weights to adjust for these differences are given in the Supplementary Material. The patient characteristics we chose to balance were: female age, duration of subfertility, primary or secondary subfertility, total motile sperm count, referral status, presence of one-sided tubal pathology and fertility clinic (Hunault et al., 2004; van Eekelen et al., 2017a) . We calculated the mean weight, which is ideally around 1 to avoid inflating the effective sample size (Cole and Hernan, 2008) .
We assessed the degree of balance in patient characteristics before and after weighting using the standardized mean difference between the treated and untreated group. A lower standardized mean difference between groups represents better balance and a value below 0.10 generally indicates no important difference (Austin, 2011; Austin and Stuart, 2015) .
Statistical analysis
We analysed the weighted datasets using a pooled Cox proportional hazards model with IUI-OS or expectant management as a treatment covariate. We calculated an overall hazard ratio by stratifying on all 13 mimicked trials. We used a robust sandwich variance estimator to adjust precision measures since couples can be included in multiple trials (Wei et al., 1989) . Using the pooled Cox model, we predicted the probability of conception over 6 months when couples start IUI-OS immediately after completion of the fertility workup or when they remain on expectant management.
Modification of the estimated effect of IUI-OS by the prognosis of natural conception
To address whether the effect of starting IUI-OS depends on the decreasing prognosis of natural conception of the individual couple, we added a treatment-by-prognosis interaction term to the model. We calculated a time-updated prognosis of natural conception over the next six cycles at the start of each mimicked trial dataset by using the dynamic prediction model that comprises female age, duration of subfertility, primary or secondary subfertility, percentage of progressive motile sperm and referral by a general practitioner or specialist (van Eekelen et al., 2017a) . The prognosis for a couple is thus not one fixed value throughout the study, but decreases after consecutive failed natural cycles. We included the complementary log-log of this updated prognosis as a main effect, the main effect for treatment and the treatment-by-prognosis interaction effect in the pooled Cox model. The weighting procedure was adjusted slightly for this analysis (VanderWeele, 2009) because the difference in prognosis between groups was adjusted for by adding it to the model as a main effect (see also Supplementary Material).
For three hypothetical couples, we visually depicted the relationship between their worsening prognoses and the accompanying 6-month cumulative predicted probability of conception following expectant management or starting IUI-OS, shown as treatment is initiated later. The first example is a couple referred by their general practitioner, where the female partner is nulliparous and 32 years old, the couple has 1 year of subfertility at the time of completion of the fertility workup and the semen analysis showed 37% progressively motile sperm. In this case, the estimated prognosis of natural conception over the next six cycles is 25%. A second couple with the same characteristics except for a 2-year duration of subfertility at the completion of the fertility workup has a prognosis of 20% while a third couple with the same characteristics but for a 3.5-year duration of subfertility has a prognosis of 15%. At the time of the completion of their fertility workup, these couples have prognoses of 25, 20 and 15%, respectively, over six cycles, which translates to~40, 32 and 25%, respectively, over 13 cycles, i.e. 1 year (van Eekelen et al., 2017a).
If these three hypothetical couples should fail to conceive naturally over the course of 1 year after completion of the fertility workup, i.e. if they would 'enter' the latest mimicked trial, their prognoses over the next six cycles decrease to 13, 10 and 7%, respectively.
Estimated cumulative probabilities of ongoing pregnancy from this model are derived from the separate mimicked trials that all have different observed conception rates, thus predictions may fluctuate. We considered an absolute difference of more than 5% between point estimates of the cumulative ongoing pregnancy rates, estimated at the completion of the fertility workup, to signify a benefit of IUI-OS.
In addition to the impact of prognosis or a failure to conceive in consecutive natural cycles on the effect of treatment, we modelled if the effect of IUI-OS depends on the time of initiation of treatment by adding an additional interaction between treatment and landmark time point to the pooled Cox model already including treatment, prognosis and the treatment-by-prognosis interaction. We also added a three-way interaction between treatment, prognosis and landmark time point to the previous model to see if the effect modification of prognosis on IUI-OS changed over mimicked trials, i.e. when starting treatment later.
As a sensitivity analysis, we tested whether couples with mild male subfertility had more or less benefit from IUI-OS compared to couples that did not have mild male subfertility. We classified couples as having mild male subfertility when they had a total motile count between 1 and 10 × 10 6 , then tested the hypothesis by fitting a Cox model including treatment, the mild male subfertility classification and their interaction.
We used Akaike's Information Criterion (AIC) and Wald tests for the interaction terms to determine whether including the interactions resulted in a better fit of the model to the data (Akaike, 1974) .
Missing data
Missing data were accounted for using multiple imputation in a previous study, creating 10 imputation sets (van Eekelen et al., 2017a) . In total, only 1.3% of patient characteristic data used for this study were missing and we chose to use one randomly selected imputation set for our analyses.
All statistical analyses were performed using R version 3.3.2 (R Core Team, 2013) using the survival, dynpred and CreateTableOne packages.
Results
From the 7860 couples included in the initial cohort, we selected 1896 couples for analysis (Fig. 1) .
Of these, 800 couples had at least one IUI cycle within 1.5 years after the workup for a total of 3119 cycles (Table I) following which 142 couples conceived leading to ongoing pregnancy (rate: 0.50 per couple per year over a median follow up for IUI of 4 months). Out of 1096 untreated couples followed up for 1.5 years after the fertility workup, 386 conceived naturally leading to ongoing pregnancy (rate: 0.31 per couple per year over a median follow up of 7 months). Among couples who remained on expectant management, there were 5 multiple pregnancies, 68 women miscarried and 7 had an ectopic pregnancy. Among couples treated with IUI-OS, there were 16 multiple pregnancies, 35 women miscarried and 7 women had an ectopic pregnancy.
Out of 800 couples who underwent IUI-OS, 64 started treatment directly after completion of the fertility workup and 736 had a prior period of expectant management after completion of their fertility workup. The median period between completion of the fertility workup and starting IUI-OS was 6.5 months. In 57% of IUI cycles, recombinant gonadotrophins were used, in 24% no medication was used, in 9% clomiphene citrate was used and in 7% urinary gonadotrophins were used. In 3% of cycles, another type of drug was used or data were missing. A total of 268 couples (14%) received IVF as their first treatment, with a median period of expectant management of 1 year between completion of the fertility workup and the start of IVF.
We depicted the number of couples currently in the expectant management or IUI-OS group over time in Fig. 2 . Until 10 months after the fertility workup, there was a steady increase in the number of couples who were currently in a treatment pathway, after which this number declined again.
The baseline characteristics for couples who eventually received at least one cycle of IUI-OS within 1.5 years after the fertility workup or who remained untreated are summarized in Table I . Treated couples more often had primary subfertility (70 versus 60%) and were more often tested for tubal patency using laparoscopy, hysterosalpingography or transvaginal hydrolaparoscopy (55 versus 39%) compared to couples that were not treated. Female age, on average 32.1 years old (SD: 4.4) and median duration of subfertility of 1.6 years (5th-95th percentile: 1.0-4.7), both at completion of the fertility workup, were similar between groups.
In the weighted trial datasets, the standardized mean differences between treated and untreated couples were below 0.10 for all characteristics, indicating that the two groups were well balanced in terms of prognostic factors after weighting. The mean weight used in the pooled dataset was 1.00, indicating that weights are stable and do not artificially inflate sample size.
Effect estimates of IUI-OS
Starting IUI-OS was associated with increased ongoing pregnancy rates compared to expectant management as shown by an estimated hazard ratio of 1.96 (95% CI: 1.47-2.62), pooling all 13 mimicked, weighted trials running over 6 months. The predicted probability that a couple would conceive over the course of 6 months of expectant management after the fertility workup was 17% (95% CI: 16-19%) . If the couple started IUI-OS directly after completion of the fertility workup, their estimated probability of conception was 31% (23-38%) over that same period.
The relative effect of IUI-OS depended on the prognosis of natural conception (P = 0.01).
The relationship between prognosis and the estimated treatment effect as time progresses is visualized in Fig. 3 , in which estimated 6-month cumulative probabilities of conception with and without starting IUI-OS are shown for three different example couples with a prognosis to conceive naturally at completion of the fertility workup over the next six cycles of 25% (A), 20% (B) or 15% (C), which were updated over time when these couples fail consecutive natural cycles and start treatment later.
The absolute cumulative predicted probability to conceive over 6 months after starting IUI-OS was stable at around 24%, regardless of the prognosis at completion of the workup or the time thereafter when a couple would start, which leads to larger differences between IUI-OS and expectant management for couples at lower prognoses of natural conception and/or for couples after additional failed natural cycles, both on absolute and relative scale.
It follows from Figure 3 that a couple who has tried to conceive for 3.5 years post fertility work up with a prognosis of 15% over the next 6 months (~25% over 1 year) has a higher predicted probability when starting treatment directly after completion of the fertility workup compared to expectant management, whereas a couple who tried to conceive for 1 year with a prognosis of 25% (~40% over 1 year) does not.
Apart from the influence of decreasing prognosis over time, we found no evidence that the relative effect of IUI-OS changed as treatment was started later (P = 0.38) nor that the dependency of the relative effect of IUI-OS on prognosis additionally depended on when treatment was started (P = 0.66). We found no evidence for a 
Table I
Baseline characteristics of patients in the original dataset at completion of the fertility workup (n = 1896) and the total number of IUI cycles they underwent. Data are mean or median (5th-95th percentile) or n (%).
Couples who remained on expectant management (n = 1096)
Couples who received at least one IUI cycle within 1.5 years (n = 800) difference in the benefit of IUI-OS between couples with or without mild male subfertility (P = 0.75).
Discussion
In couples with unexplained subfertility, starting IUI-OS within 1.5 years after completion of the fertility workup was associated with increased ongoing pregnancy rates over 6 months compared to expectant management. The estimated benefit of treatment depended on the prognosis of natural conception, not only expressed at the time of completion of the fertility workup but also after additional failed natural cycles. Our study has a number of strengths. First, the chosen study design represents the best possible design for an observational study, being less subject to selection bias than a comparison of separate cohorts since unexplained subfertile couples that will eventually be treated or not were both sampled using a prospective approach and followed up thereafter (Aboulghar et al., 2009; McLernon et al., 2014; van Eekelen et al., 2017b) . In addition, we were able to adjust for differences in prognostic factors between treated and untreated couples and the relatively large sample size and long follow up meant we were able to study whether the prognosis of natural conception influences the effect of IUI, an approach aimed to improve the management of unexplained subfertile couples and to explain the discrepancies between existing trials.
Second, data collection took place before the current Dutch clinical guideline for fertility recommending the application of the prediction model for natural conception leading to live birth by Hunault et al. to decide on treatment (NVOG, 2010) . Because decisions regarding treatment were not clear-cut at the time, this led to considerable variation in observed time points when couples started IUI and ensured that most couples would be eligible for treatment, reducing confounding by indication.
Third, we defined the IUI period as the time between the first and last cycle, even when treatment cycles were not consecutive, which is a realistic measure of the actual time that couples spend in an IUI programme. This allowed comparison with expectant management on the same axis representing 'real' calendar time and allows our results to be easily interpreted (Daya, 2005) .
Fourth, we focused on the clinical question on what would occur when treatment would be started at a given time point and applied methodology that matched this question. When analysing the data using a regular Cox approach with a time-varying covariate for treatment, the couples currently undergoing IUI at a certain point in time consist of couples who just started and couples who already failed several cycles, such that the resulting estimate would be different from 'starting IUI' and more difficult to interpret (Gran et al., 2010) .
Our study also has some limitations. An adequately powered, randomized controlled trial offers the best way of evaluating the effectiveness of IUI-OS compared to expectant management; our observational study following a cohort of couples after both strategies is a less robust design because treatment was not randomly allocated, which means that treated and untreated couples might differ on important factors related to conception. We tried to balance these factors in both groups using (iterative) inverse probability weighting. Nevertheless, our results could still be influenced by unmeasured factors related to conception, i.e. Figure 3 The association between the predicted prognosis of natural conception and the estimated benefit of starting IUI-OS. This is shown as cumulative probabilities over 6 months (y-axis) when starting IUI-OS or not at different time points after completion of the fertility workup (x-axis) for three example couples that have three different prognoses at the workup completion: 25% (panel A), 20% (panel B) or 15% (panel C). The prognosis was calculated over six cycles and updated after additional failed natural cycles. Grey bands represent 95% confidence limits. residual confounding. However, the advantage of using observational data on couples with a wide range of prognoses of natural conception was that we could directly address the hypothesis regarding the influence of prognosis on the relative effect of IUI-OS. Addressing this hypothesis with an experimental design would require the unfeasible, inefficient and indirect approach of conducting multiple smaller, separate trials applying different inclusion criteria.
The primary outcome was ongoing pregnancy since following couples for live birth increases logistical efforts that the study budget did not allow for. In addition, following couples for live birth increases the likelihood of loss-to-follow-up. Ongoing pregnancy is generally considered an appropriate and efficient proxy for live birth in clinical research:~95% of ongoing pregnancies lead to live birth (Clarke et al., 2010; Braakhekke et al., 2014) .
Overall, 54% of couples only received a CAT and not a visual test for tubal patency. It is unlikely that this has led to clinically relevant differences in tubal pathology between treated and untreated couples because the decision to initiate IUI-OS was taken in the absence of visual confirmation of tubal patency and thus, any difference is likely due to chance.
We lacked the sample size to accurately estimate interactions between all separate patient characteristics female age, duration of subfertility, etc. and IUI-OS to further individualize treatment effects. Instead, we opted for the summary score in terms of an estimated prognosis such that only one additional parameter was required (Dahabreh et al., 2016) and updated this over time using our previously developed dynamic model for natural conception to determine when a couple would benefit from starting treatment (van Eekelen et al., 2017a) .
Our findings add context to the apparent discrepancies between the two randomized controlled trials that compared IUI-OS to expectant management (Steures et al., 2006; Farquhar et al., 2018) . Steures et al. included 253 couples with an intermediate prognosis for natural conception, i.e. 30-40% as calculated by the Hunault model and found a risk ratio of 0.85 (95% CI: 0.63-1.10) for ongoing pregnancy after IUI-OS compared to expectant management over the course of 6 months. The pragmatic TUI trial by Farquhar et al. included 201 couples with a prognosis <30% and found a beneficial effect of IUI-OS compared to expectant management by a risk ratio of 3.41 (95% CI: 1.71-6.79). Couples in the latter study had a much worse prognosis of natural conception compared to the first; mostly due to an average duration of subfertility of 3.6 years that was almost double the average duration in the trial by Steures et al. and in the present study. Our finding that the benefit of IUI-OS is larger in couples with poorer prognoses of natural conception, both on relative and absolute scale, may primarily explain and support the difference in results.
Couples with a prognosis of natural conception of 25% over 6 months (~40% over 1 year) or higher were not expected to benefit from IUI-OS. For couples with a prognosis around 20% over 6 months (~32% over 1 year), it was uncertain if we can expect a clinically relevant benefit of IUI-OS. Couples with a prognosis of 15% over 6 months (~25% over 1 year) or lower were expected to benefit from IUI-OS as the absolute difference in pregnancy rates was more than 5%.
Since IUI-OS is invasive, expensive and associated with potential disadvantages such as ovarian hyperstimulation or multiple pregnancies (Rooney and Domar, 2016) , we believe that counselling couples should involve a discussion about their prognosis when following alternative treatment scenarios so that they are able to make an informed choice. These results, in combination with the prognosis of natural conception derived from a prediction model (van Eekelen et al., 2017a) , can be used to attain that goal.
Because confidence intervals around the predicted pregnancy rates after IUI-OS for a given prognosis were broad in the current study, the results need to be interpreted with caution and replicated in further research.
Conclusion
Within 1.5 years post fertility workup, starting IUI-OS is associated with higher chances of conception in couples with unexplained subfertility and a poor prognosis for natural conception, i.e. <15% over 6 months or <25% over 1 year. Our results explain the discrepancies between two trials that compared IUI-OS to expectant management using different inclusion criteria for the prognosis of natural conception. These results may be used in counselling couples with unexplained subfertility. Future studies should focus on establishing the threshold for the prognosis of natural conception at which IUI-OS is deemed (cost-)effective.
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